Page last updated: 2024-12-08

wyosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

wyosine: derivative of tricyclic guanine nucleus; see also record for wye (base); structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

wybutosine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

wybutosine : A nucleoside analogue having methyl (2S)-4-(4,6-dimethyl-9-oxo-4,9-dihydro-3H-imidazo[1,2-a]purin-7-yl)-2-[(methoxycarbonyl)amino]butanoate as the modified nucleobase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID171185
CHEBI ID188917
MeSH IDM0058877
PubMed CID14135916
CHEBI ID46574
MeSH IDM0058877

Synonyms (36)

Synonym
nsc628338
{3h-diimidazo[1,2-a:4',5'-d]pyrimidin-9-one,} 4,9- dihydro-4, 6-dimethyl-3-b-d-ribofuranosyl-
3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-4,6-dimethyl-imidazo[1,2-a]purin-9-one
wyosine
IMG ,
wyosin
CHEBI:188917
52662-10-9
3-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethylimidazo[1,2-a]purin-9-one
y base 3-beta-d-ribofuranoside
3-ribofuranosyl-4,9-dihydro-4,6-dimethyl-9-oxo-1h-imidazo(1,2-a)purine
y nucleoside
yt nucleoside
9h-imidazo(1,2-a)purin-9-one, 3,4-dihydro-4,6-dimethyl-3-beta-d-ribofuranosyl-
DTXSID70200631
Q2595726
3-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6-dimethyl-3h-imidazo[1,2-a]purin-9(4h)-one
STARBLD0002298
AKOS040754434
CHEBI:46574
wybutosine
7-{(3s)-4-methoxy-3-[(methoxycarbonyl)amino]-4-oxobutyl}-4,6-dimethyl-3-(beta-d-ribofuranosyl)-3,4-dihydro-9h-imidazo[1,2-a]purin-9-one
(s)-methyl 4-(3-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6-dimethyl-9-oxo-4,9-dihydro-3h-imidazo[1,2-a]purin-7-yl)-2-((methoxycarbonyl)amino)butanoate
55196-46-8
HY-142994
STARBLD0005718
CS-0374738
DTXSID401030490
3h-imidazo(1,2-a)purine-7-butanoic acid, 4,9-dihydro-.alpha.-((methoxycarbonyl)amino)-4,6-dimethyl-9-oxo-3-.beta.-d-ribofuranosyl-, methyl ester, (.alpha.s)-
(alphas)-alpha-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-beta-d-ribofuranosyl-4,9-dihydro-3h-imidazo[1,2-alpha]purine-7-butanoic acid methyl ester
nucleoside y
nucleoside y, from saccharomycescerevisiae
unii-5pcy5as87q
3h-imidazo(1,2-a)purine-7-butanoic acid, 4,9-dihydro-alpha-((methoxycarbonyl)amino)-4,6-dimethyl-9-oxo-3-beta-d-ribofuranosyl-, methyl ester, (alphas)-
5pcy5as87q ,
(alphas)-alpha-((methoxycarbonyl)amino)-4,6-dimethyl-9-oxo-3-beta-d-ribofuranosyl-4,9-dihydro-3h-imidazo(1,2-alpha)purine-7-butanoic acid methyl ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (5)

ClassDescription
nucleobase-containing molecular entityAny compound that has a nucleobase as a part.
carbohydrate derivativeAny organooxygen compound derived from a carbohydrate by replacement of one or more hydroxy group(s) by an amino group, a thiol group or similar heteroatomic groups. The term also includes derivatives of these compounds.
nucleoside analogueAn analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (12.82)18.7374
1990's1 (2.56)18.2507
2000's13 (33.33)29.6817
2010's17 (43.59)24.3611
2020's3 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.37 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews4 (25.00%)6.00%
Reviews8 (30.77%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other12 (75.00%)84.16%
Other18 (69.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]